Amwell® Research is built on years of clinical evidence
Years of Research Heritage
Peer reviewed research papers
Active research projects
PRESENTATIONS AT INTERNATIONAL CONFERENCES
Our researchers are highly qualified scientists, covering our wide research agenda and collaborating with leading academic and research institutions across the globe. We are at the cutting edge in digital therapeutics , publishing our research in high-impact peer-review publications and presenting at top international conferences.
Effectiveness research is one of the core research pillars at Amwell® Research. A distinct feature of our effectiveness trials is that they are all pragmatic studies conducted in real-world settings which maximizes the ecological validity and generalizability of the findings. We have conducted Randomized Controlled Trials (RCTs) that have proven that the programs we are offering are effective at addressing different mental health conditions. Amwell® Research has demonstrated positive long-lasting outcomes resulting in significant improvement in symptoms after 12 months.
Every user is unique and therefore so is their usage of the platform. Research on usage and engagement is key to understanding behaviors and patterns that lead to outcomes and driving innovation. Using world-class AI and Machine Learning methods, Microsoft Labs Cambridge and Amwell® Research have published data highlighting usage levels that are attributed to positive results. This work could help to leverage any predictive models of engagement and inform the build of innovative dynamic interventions.
This work provides an up-to-date examination of the available intervention options and their effectiveness for children and young people (CYP).
This pilot study examined the preliminary effects of a digital program on financial difficulties and mental health within an routine clinical setting. The results showed patients experienced significant improvements in depression, anxiety and perceived financial wellbeing. Satisfaction rates with the program were at 95%, suggesting it was highly accepted.
This study is the first to explore the remission and relapse rates after an acute phase of iCBT treatment, within a routine, stepped-care setting. The results add to the scarce literature on the durability of the effects of iCBT treatment in routine care settings, where patients are not typically followed up after receiving a completed course of treatment.
Angel joined Amwell® in 2017. He holds a PhD in Psychopathology, Health and Neuropsychology from University Jaume I (Spain). His main role is to lead the design, planning and execution of research projects on internet-delivered interventions for different mental health conditions. Angel is a prolific researcher with many years of experience in the Digital Mental Health Space where he has worked with different academic institutions and lead experts across Europe and US. He has experience in both, industry and academia fields, and leveraging the best from both sides to advance the science behind these interventions.
Daniel has worked as a clinical researcher with Amwell® since 2015 and has managed several clinical trials, including the Digital IAPT RCT and investigations into the utility of iCBT for patients with severe presentations of depression and anxiety in NHS services. His research interests centre on the intersection between the fields of implementation science and digital therapies, and he has recently been awarded an employment-based postgraduate scholarship by the Irish Research Council to conduct doctoral research in this area. This research is supported by both Amwell® and the E-Mental Health Research Group at Trinity College Dublin, and is due for completion in 2021
Catalina joined Amwell® in 2020 after completing her Doctorate degree in Personal Health Informatics, a joint degree between Northeastern University’s schools of health and computer sciences, with a focus on improving health through patient-facing, transdisciplinary, and innovative solutions. She has experience working with vulnerable populations and assessing the feasibility of using new technologies for data collection, as well as their impact on behavioral interventions in underserved populations. With a background in both psychology and computer science, Catalina is passionate about leveraging technology to help people and is bringing her interdisciplinary experience into designing, executing, and evaluating new research at Amwell®.
Adedeji Adegoke is a Clinical Research Associate (Data Management) at Amwell® who obtained his MSc in Data Analytics from the School of Computing in National College of Ireland. Adedeji’s interest lies in using big data to pilot research and innovation within internet-delivered mental health interventions. He is skilled in sophisticated statistical analyses, data analysis and research methodologies.
Dr. David Barlow is Founder and Director Emeritus, Center for Anxiety and Related Disorders, Professor Emeritus of Psychology and Psychiatry at Boston University. His clinical research focuses on understanding the nature of anxiety and depression and developing new treatments for emotional disorders.
Dr. Polonsky is the President of the Behavioural Diabetes Institute and Associate Clinical Professor in Psychiatry at the University of California San Diego. He received his PhD in clinical psychology from Yale University and has served as Senior Psychologist at the Joslin Diabetes Center in Boston, faculty member at Harvard Medical School and Chairman of the National Certification Board for Diabetes Educators.
Ladislav Timulak, PhD is Director of the Doctorate in Counselling Psychology at School of Psychology, Trinity College Dublin, Ireland. His research focuses on various aspects of the delivery of psychological therapies for a range of mental health difficulties, including randomized controlled trials in both face-to-face and online internet-delivered therapy.
Dr. Farchione is a Research Professor at Boston University and directs the Intensive Treatment Program for Panic Disorder and Specific Phobias . His research interests are focused on the psychological factors associated with the development of anxiety and mood disorders. In particular, he is interested in the development of more effective treatments for these disorders and is currently working with Dr. David Barlow investigating a new unified transdiagnostic treatment for anxiety and mood disorders.
Our News and Events
This study is the first of its kind in that brought together data insights about the mental health concerns of millions of people in regard to the covid-19 pandemic from more than 50 providers related to digital mental health and financial servicesLearn More
Our Chief Science Office, Derek Richards, participated in the Banbury Forum, which gathered the most influential and expert leaders in the Digital Mental Health Space and Digital Therapeutics. This forum resulted in several recommendations that need to be followed to ensure a proper deployment and implementation of digital mental health solutions.
Our research team designed a 3-arm controlled trial to compare the effects of the program offered with and without coaching in a sample of college students. The results of our pilot study demonstrated significant improvements in wellbeing, resilience and self-esteem at post-intervention in a sample of college students.Learn More
Our research team conducted a systematic review and meta-analysis on the effectiveness of internet-delivered interventions for Generalized anxiety disorder (GAD). Twenty controlled studies were included with a total of 1333 participants. Results showed that these interventions produce large effects on outcomes of anxiety and worry.